I also reckon its a done deal, and right now probably will be taken up. But I'm just not expecting much more from here, which isn't bad from a few months ago.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025